Mutagenesis of human immunodeficiency virus reverse transcriptase p51 subunit defines residues contributing to vinylogous urea inhibition of ribonuclease H activity.
about
Complexes of HIV-1 RT, NNRTI and RNA/DNA hybrid reveal a structure compatible with RNA degradationStructural analysis of monomeric retroviral reverse transcriptase in complex with an RNA/DNA hybridStructural Maturation of HIV-1 Reverse Transcriptase-A Metamorphic Solution to Genomic InstabilityRibonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6Inhibition of foamy virus reverse transcriptase by human immunodeficiency virus type 1 RNase H inhibitorsThe nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors.Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise.Inhibitors of HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity.Examining the role of the HIV-1 reverse transcriptase p51 subunit in positioning and hydrolysis of RNA/DNA hybridsExploiting drug-resistant enzymes as tools to identify thienopyrimidinone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H.Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase.Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives.Reverse transcriptase backbone can alter the polymerization and RNase activities of non-nucleoside reverse transcriptase mutants K101E+G190S.Structure-guided approach identifies a novel class of HIV-1 ribonuclease H inhibitors: binding mode insights through magnesium complexation and site-directed mutagenesis studies
P2860
Q27675888-004EBE0E-040F-42BD-963C-5BFF08162F7BQ27676135-E796C03E-7929-4ACF-BD58-3314620BBC14Q28074527-4D665369-1F2E-4602-A740-900249BBC2ECQ28552768-C1631C3F-334F-4877-80EA-C3B918E55CC9Q33798319-945492CB-79F0-4F76-9F68-30FD737EF7E2Q34991047-0FF7D869-6280-45DA-BFAA-54C9051941EFQ35962212-EE92D7FE-09B2-4261-BEB9-8A037CDC2386Q36435971-C2D4DE75-7FF7-4886-ABF2-55418E00DF2BQ36768814-5B05F576-374A-4C43-A3CB-AFEF9E637686Q36890771-ED21F5D5-0849-4E55-BC8B-551A5453E5A3Q37432679-BD9C1E1C-DDF2-4A49-83AC-26646E8ADF41Q38164838-9EA4B3AC-EA72-4B68-9F0D-DB3754264E43Q38968700-CFC767BB-5D5A-49D5-848C-AC9ECCA5C3E6Q42159090-0E25E644-C019-483C-97CC-A46C006DE469Q58196866-24914437-90DB-4ACC-99DA-B4DB98FEED5F
P2860
Mutagenesis of human immunodeficiency virus reverse transcriptase p51 subunit defines residues contributing to vinylogous urea inhibition of ribonuclease H activity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mutagenesis of human immunodef ...... on of ribonuclease H activity.
@ast
Mutagenesis of human immunodef ...... on of ribonuclease H activity.
@en
type
label
Mutagenesis of human immunodef ...... on of ribonuclease H activity.
@ast
Mutagenesis of human immunodef ...... on of ribonuclease H activity.
@en
prefLabel
Mutagenesis of human immunodef ...... on of ribonuclease H activity.
@ast
Mutagenesis of human immunodef ...... on of ribonuclease H activity.
@en
P2093
P2860
P356
P1476
Mutagenesis of human immunodef ...... on of ribonuclease H activity.
@en
P2093
Barry C Johnson
Jennifer T Miller
Stuart F J Le Grice
Suhman Chung
P2860
P304
P356
10.1074/JBC.M111.314781
P407
P577
2011-11-21T00:00:00Z